X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
3.370
-0.110 (-3.16%)
At close: Oct 6, 2025, 4:00 PM EDT
3.490
+0.120 (3.56%)
After-hours: Oct 6, 2025, 7:48 PM EDT
X4 Pharmaceuticals Market Cap
X4 Pharmaceuticals has a market cap or net worth of $75.66 million as of October 6, 2025. Its market cap has decreased by -36.15% in one year.
Market Cap
75.66M
Enterprise Value
93.20M
1-Year Change
-36.15%
Ranking
Category
Stock Price
$3.37
Market Cap Chart
Since March 14, 2019, X4 Pharmaceuticals's market cap has decreased from $101.77M to $75.66M, a decrease of -25.66%. That is a compound annual growth rate of -4.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 78.12M | -37.56% |
| Dec 31, 2024 | 125.11M | -10.81% |
| Dec 29, 2023 | 140.27M | 16.23% |
| Dec 30, 2022 | 120.68M | 87.36% |
| Dec 31, 2021 | 64.41M | -38.49% |
| Dec 31, 2020 | 104.72M | -39.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |